June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Prognostic Factors after Treatment of Patients with Retinal Capillary Hemangioma(RCH)
Author Affiliations & Notes
  • Hyesun Kim
    Department of Ophthalmology, Yonsei University Severance Hospital, Seoul, Republic of Korea
  • Jeong Ho Yi
    Department of Ophthalmology, Yonsei University Severance Hospital, Seoul, Republic of Korea
  • Hee Jung Kwon
    Department of Ophthalmology, Yonsei University Severance Hospital, Seoul, Republic of Korea
  • Christopher Lee
    Department of Ophthalmology, Yonsei University Severance Hospital, Seoul, Republic of Korea
  • SungChul lee
    Department of Ophthalmology, Yonsei University Severance Hospital, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Hyesun Kim, None; Jeong Ho Yi, None; Hee Jung Kwon, None; Christopher Lee, None; SungChul lee, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5884. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyesun Kim, Jeong Ho Yi, Hee Jung Kwon, Christopher Lee, SungChul lee; Prognostic Factors after Treatment of Patients with Retinal Capillary Hemangioma(RCH). Invest. Ophthalmol. Vis. Sci. 2013;54(15):5884.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To report observations regarding the regression and visual outcome after treatment of eyes with retinal capillary hemangioma (RCH)

Methods: Retrospective consecutive case series. A total of 37 eyes of 32 patients with RCH were included in this study. Data were analyzed for basic characteristics, regression of RCH and visual outcome after treatment.

Results: The mean age at diagnosis in cases with RCH was 30.6 year (range, 5~56 years).The RCH was bilateral in 6 cases (19%), and von Hippel-Lindau disease was positive in 15 cases(47%). Seven of tumors (19%) touched optic disc and were classified as juxtapapillary RCH, and the remaining 30 (81%) were extrapapillary in location. Twenty (54%) cases were single tumor and 17(46%) were multiple (mean: 2.4, range:1~21). Nine (24%) RCH were 1.5mm or smaller and 3 (8%) were larger than 6mm in size. Initially accompanying exudation, serous fluid and retinal detachement were 27 (73%), 11 (30%) and 7 (19%).Twenty four (75%) of 32(87%) treated RCH were regressed. The mean number of treatment was 1.87 (range, 1~9) and cases experienced complication after treatment was 17 (53%). RCH was treated in 29 of 30(97%) extrapapillary cases vs 4 of 7(57%) juxtapapillary cases (p<0.001). Visual improvement after the treatment was significantly related to the regression of RCH after the treatment (p=0.024) and the number of treatment(1.26 vs 2.50, p=0.02). Multivariate logistic regression identified the regression of RCH after the treatment(p=0.028,odds ratio=13.76;confidence interval=1.3,142) as predictive factor for visual improvement. Better final vision (>20/50) was significantly related to initial better vision (>20/50) (p=0.0002), regression of RCH (p=0.0014), absence of retinal detachement (RD) (p=0.012), absence of complication after treatment (p=0.015), initially no need for treatment (p=0.036).

Conclusions: This study suggests that the prognostic factors for better visual outcome after treatment of RCH are initial better vision, regression of RCH, absence of retinal detachement (RD), absence of complication after treatment, initially no need for treatment.

Keywords: 744 tumors  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×